Leslie's, Inc. filings document the company's pool and spa care retail business, operating results, public-company governance, and capital structure. Form 8-K reports cover quarterly financial results, strategic transformation disclosures, leadership and board changes, auditor changes, shareholder votes, Nasdaq listing compliance, and amendments affecting common stock.
Proxy materials describe director elections, executive compensation, auditor ratification, incentive-plan matters, and certificate-of-incorporation proposals. The filing record also documents completed capital-structure actions, including a reverse stock split and related changes to authorized shares, as well as internal-control disclosures tied to inventory and asset impairment processes.
Naylor Maile reported acquisition or exercise transactions in this Form 4 filing.
Leslie's, Inc. director Maile Naylor reported receiving 4,500 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Leslie's common stock upon vesting.
The 4,500 RSUs will vest on the earlier of March 24, 2027 or the day before the company’s 2027 annual shareholder meeting, as long as Naylor continues serving on the board through that vesting date.
Leslie's, Inc. director Claire Spofford reported an equity compensation award rather than a market trade. She acquired 4,500 Restricted Stock Units (RSUs), each representing the right to receive one share of common stock upon vesting. The RSUs will vest on the earlier of March 24, 2027 or the day before the company’s 2027 annual shareholder meeting, as long as she continues serving on the board. Following this grant, her reported direct position related to this award is 4,500 shares, reflecting a routine director compensation grant with no shares sold.
Strain John reported acquisition or exercise transactions in this Form 4 filing.
Leslie's, Inc. director John Strain reported an equity award of 4,500 restricted stock units (RSUs). Each RSU represents the right to receive one share of Leslie's common stock upon vesting. The 4,500 RSUs will vest on the earlier of March 24, 2027 or the day before the company’s 2027 annual shareholder meeting, provided he continues serving on the board through that date.
Leslie's, Inc. director Claire Spofford exercised 7,281 Restricted Stock Units into an equal number of common shares on March 12, 2026. The RSUs converted at a price of $0.00 per unit as part of equity compensation. Following the transaction, she directly holds 10,983 common shares. No shares were sold, so this reflects an exercise-and-hold decision rather than a market sale.
Leslie's, Inc. director Lorna Nagler exercised restricted stock units into common shares. On 2026-03-12, she converted 7,281 Restricted Stock Units into 7,281 shares of Leslie's common stock at a stated exercise price of $0.00 per share.
Following these transactions, Nagler directly owned 8,732 shares of Leslie's common stock. The filing shows an exercise-and-hold pattern, with no reported open-market sales or tax-withholding dispositions in this Form 4.
Leslie's, Inc. director Daniel Yolanda acquired 7,281 shares of common stock on March 12, 2026 by exercising an equal number of Restricted Stock Units, which convert into one share each upon vesting. After this compensation-related exercise, Yolanda directly holds 9,794 common shares.
Leslie's, Inc. director Naylor Maile exercised restricted stock units and increased their shareholdings. On this Form 4, Maile exercised 7,281 Restricted Stock Units, each converting into one share of Leslie's common stock at a price of $0.00 per share. Following the conversion, Maile directly holds 9,298 shares of Leslie's common stock, indicating an exercise-and-hold transaction with no reported share sales.
Leslie's, Inc. director John Strain reported an exercise of equity awards rather than an open‑market trade. On March 12, 2026, he exercised 7,281 Restricted Stock Units, receiving the same number of shares of common stock at a stated price of $0.00 per share.
After this transaction, Strain directly holds 12,627 shares of Leslie's common stock. A separate holding entry shows an additional 13,500 shares of common stock held indirectly by the Strain Family Revocable Trust. The filing shows no remaining derivative positions from this RSU grant.
Leslie's, Inc. officer Naomi Cramer reported compensation-related equity activity. On March 14, 2026, a total of 6,428 Restricted Stock Units converted into the same number of common shares. To cover tax obligations, 2,035 shares of common stock were withheld and disposed of at $1.18 per share.
After these transactions, Cramer directly holds 9,007 shares of Leslie's common stock. Footnotes also describe new RSU grants of 10,000 and 2,854 units that will vest in equal parts on March 15, 2027 and March 14, 2028, if she remains continuously employed.
Leslie’s, Inc. reported a weak first quarter as sales and margins fell sharply and store closures weighed on results. Sales declined to $147.1 million from $175.2 million, with comparable sales down 15.5%. Gross margin compressed to 18.4% from 27.2%, hurt by a $6.4 million inventory impairment tied to a strategic plan to close 80 underperforming stores and one distribution center and by lower margins on core chemicals.
The company recorded total charges of about $18.5 million related to the closures, contributing to an operating loss of $68.7 million and a net loss of $83.0 million, versus a $44.6 million loss a year earlier. Adjusted EBITDA was a loss of $40.3 million. Cash used in operating activities improved but remained heavy at $81.1 million. Cash and cash equivalents fell to $3.6 million, while total debt stood at $781.7 million, including a Term Loan due 2028 and $25.0 million drawn on the Revolving Credit Facility, with $128.3 million of remaining availability.
The quarter also reflected the earlier 1-for-20 reverse stock split and prior goodwill impairment, leaving no goodwill on the balance sheet. Management disclosed that previously identified material weaknesses in internal control over financial reporting remain unremediated, so disclosure controls and procedures were not effective. During the quarter, the company received a credit rating downgrade from S&P Global Ratings to CCC from CCC+ and continues to face pending securities class action and derivative litigation, which it plans to defend while maintaining that reserves for routine claims are not significant.